This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Covalon To Showcase New Wound Healing And Infection Management Products At MEDICA

Stocks in this article: COV

TORONTO, Nov. 19, 2013 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, will showcase new products at MEDICA the world's largest medical technology trade fair, November 20 to 23 in Düsseldorf, Germany.

Brian Pedlar, Covalon's Chief Executive Officer said, "Since we announced the transformative license agreement with Molnlycke earlier this month, the amount of interest in our new product pipeline has spiked significantly.  As a result, we have accelerated the unveiling of our FDA-cleared ColActive ® Transfer wound dressing and our CovaCoat™ A.I. Anti Infective coatings.  Along with our proven ColActive ® Plus wound dressings and SilverCoat™ Antimicrobial Foley Catheters, our strong pipeline of new products and technologies, which includes ColActive ® Transfer and CovaCoat™ A.I., positions Covalon well as a partner for wound care, urological, vascular access, surgical and orthopaedic companies and distributors."

The latest addition to the patented ColActive™ family of wound care products being showcased at MEDICA is ColActive ® Transfer, Covalon's bio-degradable wound dressing that stimulates wound healing responses in difficult to heal wounds, while allowing wound fluids to pass through the dressing.  ColActive ® Transfer is designed to protect new-growth tissue in wounds undergoing treatment and is FDA approved for sale in the United States.  Along with the introduction of ColActive ® Transfer, Covalon anticipates entering the nearly US$500 million negative pressure dressing and kit market.

Covalon will also be unveiling its new patented CovaCoat™ A.I. Anti Infective coating technology that provides antimicrobial and anti-thrombogenic properties, without eluting antimicrobial agents from the surface of medical devices. Covalon's CovaCoat™ A.I. Anti Infective Foley Catheter significantly reduces biofilm formation on urinary catheters, the formation of which is a major source of hospital acquired infections.  The use of CovaCoat™ A.I. on vascular access devices provides both anti-thrombogenic and antimicrobial characteristics without the downside of delivering potentially cytotoxic antimicrobial agents directly into the bloodstream.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs